NCT06502964Phase 2Recruiting

Study of ALTO-101 in Patients With Schizophrenia

Study sponsor: Alto Neuroscience

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2026-02Estimated
Enrollment · participants82Estimated
Source updated2025-12-26Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Primary completion date changed

− Before

Oct 2025

+ After

Feb 2026

Check registry source